Novartis Ag (NVS) Total Debt (2009 - 2025)

Novartis Ag (NVS) has 11 years of Total Debt data on file, last reported at $28.7 billion in FY2025.

• Quarterly Total Debt changed N/A year-over-year to -$19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.0 million (changed N/A YoY) and the FY2025 annual result came in at $28.7 billion, up 30.54% from the prior year.
• Total Debt improved to $28.7 billion in FY2025 per NVS's latest filing, from $22.0 billion in the prior year.
• The five-year high for Total Debt was $28.7 billion in FY2025, with the low at $19.1 billion in FY2023.
• Average Total Debt over 5 years is $23.6 billion, with a median of $22.2 billion recorded in 2021.
• Year-over-year, Total Debt decreased 27.18% in 2023 and jumped 30.54% in 2025.
• Novartis Ag's Total Debt stood at $22.2 billion in 2021, then rose by 17.87% to $26.2 billion in 2022, then declined by 27.18% to $19.1 billion in 2023, then increased by 15.47% to $22.0 billion in 2024, then jumped by 30.54% to $28.7 billion in 2025.
• Business Quant data shows NVS's Total Debt at $28.7 billion in FY2025, $22.0 billion in FY2024, and $19.1 billion in FY2023.